BONEH — BBS-Bioactive Bone Substitutes Oyj Share News
0.000.00%
Last trade - 00:00Brief: BBS-Bioactive Bone Substitutes H1 Loss For Period Widens To EUR 1.7 Mln
Brief: BBS' Rights Issue Raises Gross Proceeds Of EUR 3.5 Million
Brief: BBS Arranges Rights Issue Of Up To EUR 4.5 Mln
Brief: BBS Net Profit Swings To Loss Of EUR 2.8 Mln
Brief: BBS-Bioactive Bone Substitutes And Riverfort Signs Drawdown Of Second Advance Of Eur 250,000
Brief: BBS-Bioactive Bone Substitutes Gets Patent Granted in the U.S
Brief: BBS-Bioactive Bone Substitutes Updates On Patent Approval In USA
Brief: BBS- Bioactive Bone Substitutes H1 Consolidated Loss For The Period Narrows To EUR 1.31 Mln
Brief: BBS-Bioactive Bone Substitutes PLC Submission Moves To August
Brief: Bbs-Bioactive Bone Substitutes Oyj Reports FY 2020 Loss Per Share Eur Diluted 0.45
Brief: BBS-Bioactive Bone Substitutes: Liisa Hukka Appointed CFO
Brief: BBS-Bioactive Bone Substitutes Estimates Will Receive CE Marking For Artebone Product
Brief: BBS-Bioactive Bone Substitutes Patent Regarding Artebone Accepted In USA
Brief: BBS-Bioactive Bone Substitutes H1 Oper Loss Widens To EUR 1.4 Mln
Brief: BBS: CE Marking Application Of Co's Artebone Paste Product Is In Progress
Brief: BBS-Bioactive Bone Substitutes Rights Issue Oversubscribed
Brief: BBS-Bioactive Bone Substitutes Postpones Annual General Meeting
Brief: BBS Expects To Raise About EUR 5.5 Mln In Rights Issue
Brief: BBS-Bioactive Bone Substitutes Plans To Arrange Rights Issue Of About EUR 5.5 Mln